This is not the most recent version of the article. View current version (13 NOV 2014)

Intervention Protocol

Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer

  1. Gianpaolo Perletti1,*,
  2. Vittorio Magri2,
  3. Emanuela Marras3,
  4. Elena Monti4,
  5. Paul S Rennie5,
  6. Alberto Trinchieri6

Editorial Group: Cochrane Prostatic Diseases and Urologic Cancers Group

Published Online: 15 AUG 2012

DOI: 10.1002/14651858.CD009998


How to Cite

Perletti G, Magri V, Marras E, Monti E, Rennie PS, Trinchieri A. Second-line, post-docetaxel therapy for advanced, androgen deprivation-refractory prostate cancer (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD009998. DOI: 10.1002/14651858.CD009998.

Author Information

  1. 1

    Università degli Studi dell'Insubria, Laboratory of Toxicology and Pharmacology, Biomedical Research Division, Dept. of Theoretical and Applied Sciences, Busto A, Province of Varese, Italy

  2. 2

    Istituti Clinici di Perfezionamento, Urology/Urological Sonography Secondary Care Clinic, Milano, Italy

  3. 3

    Dept. of Theoretical and Applied Sciences, Università degli Studi dell'Insubria, Laboratory of Toxicology and Pharmacology, Biomedical Research Division, Busto A, Lombardy, Italy

  4. 4

    University of Insubria, Biomedical Research Division, Department of Theoretical and Applied Sciences, Varese, Italy

  5. 5

    University of British Columbia, Vancouver Prostate Centre, Vancouver, British Columbia, Canada

  6. 6

    A. Manzoni Hospital, Urology Unit, Lecco, Italy

*Gianpaolo Perletti, Laboratory of Toxicology and Pharmacology, Biomedical Research Division, Dept. of Theoretical and Applied Sciences, Università degli Studi dell'Insubria, Via A. da Giussano, 10, Busto A, Province of Varese, 21052, Italy. gianpaolo.perletti@uninsubria.it.

Publication History

  1. Publication Status: New
  2. Published Online: 15 AUG 2012

SEARCH

This is not the most recent version of the article. View current version (13 NOV 2014)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.